New hope for 'Chemo-Resistant' breast cancer: radiation + immunotherapy combo trial
NCT ID NCT07457359
Summary
This trial tests a 'rescue' strategy for patients with triple-negative breast cancer whose tumors don't shrink after initial chemotherapy. Participants receive a short, precise radiation treatment followed by immunotherapy combined with two chemotherapy drugs, aiming to shrink tumors enough for breast-conserving surgery. The main goal is to see if this approach can eliminate all detectable cancer by the time of surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Department of Radiation Oncology，the Second Affiliated Hospital of Zhejiang University School of Medicine, hangzhou, zhejiang
RECRUITINGHangzhou, China
Conditions
Explore the condition pages connected to this study.